The use of molecular methods for epidemiological typing of nosocomial bacterial pathogens has become a standard service for hospital infection control programs (24) . It is also an important tool for the surveillance of antibiotic-resistant pathogens, such as methicillin-resistant Staphylococcus aureus (MRSA) strains, which are causing epidemics in health care facilities. The use of in-house molecular typing methods and protocols developed by each laboratory raises the issues of standardization and quality control of these assays. The accuracy of typing methods can be checked by external quality assessment (EQA) programs. National and international EQA programs have been developed for antimicrobial susceptibility testing (3, 17, 29) . Multicenter studies have examined the interlaboratory reproducibility of newly developed methods for genotyping of pathogens of public health importance, including S. aureus (1, 4, 5, 9, 22, 30, 32) , Legionella pneumophila (14, 15) , and Mycobacterium tuberculosis (2) . However, EQA programs for molecular typing of nosocomial pathogens as a support to hospital surveillance and infection control policy have not been described.
In 2000, a network of 18 Centers for Molecular Diagnosis (CMDs) was established in Belgium by the National Disease and Disability Institute (INAMI) to provide clinically relevant molecular diagnostic tests to clinicians, including typing of nosocomial pathogens (http://webhost.ua.ac.be/cmd/). The CMD steering group agreed on indications for molecular typing. The first indication is outbreak investigation, typing of clinical isolates (and, when indicated, related environmental isolates) from presumed epidemic cases of nosocomial infection to delineate the extent of clonal spread, determine the sources, and test the hypothetical mode(s) of transmission. Typing is meant to complement the epidemiological outbreak investigation performed by the hospital infection control team to determine appropriate control measures. Bacterial isolates (Ͻ30) referred for typing must be documented by the infection control investigator by filling out a typing request form giving information about the outbreak and the origin of the isolates. The second indication is evaluation of policies for controlling the spread of multiresistant bacteria (e.g., contact isolation precautions, carrier decolonization). In the latter case, a sample of isolates from consecutive cases (maximum, 20/ year) of colonization or infection by potentially transmissible antibiotic-resistant pathogens (e.g., methicillin-resistant S. aureus, glycopeptide-resistant enterococci, multiple-antibioticresistant Enterobacter aerogenes) could be submitted for typing to complement local epidemiologic surveillance of antibiotic resistance.
To evaluate the CMD laboratories' proficiency with bacterial typing methods, we organized and conducted two EQA surveys of typing of S. aureus isolates in support of local hospital infection programs. Performance criteria included typeability, reproducibility, discrimination (D) index, and appropriate epidemiological interpretation of results to assist with testing nosocomial transmission hypotheses. (Table 1) . Strains were selected based on their genotypes by pulsed-field gel electrophoresis (PFGE) analysis. Sets of isolates with indistinguishable, clonally related, and unrelated PFGE patterns were included in each panel. PFGE patterns were classified according to a previously described system (7) . PFGE groups included profiles showing Յ6 DNA fragment differences and were designated by a capital letter (e.g., A). PFGE types included profiles showing Յ3 DNA fragment differences and were designated by the group letter followed by a roman numeral suffix (e.g., A1). A subtype included any variant PFGE profile within a type and was designated by a lowercase letter suffix (e.g., A1a). The first panel was composed of 15 S. aureus strains, including representative isolates of the epidemic MRSA strains that were most widespread in Belgium in 2001, designated BE-A1, BE-B2, and BE-C3 (8, 11) , and the second panel included 20 S. aureus strains (Table 1) . Duplicate isolates with distinct identifier codes were included in each panel for reproducibility assessment. Each panel was composed of strains subcultured in deep stab agar tubes, which were sent by the coordinating center to the 11 participating CMDs. The ULB standard c PFGE types were attributed as described previously (7); ST were determined by MLST (13); SCCmec elements were characterized by multiplex PCR (23); spa repeats and types were determined by Ridom Staph Type software (18) ; and agr groups were determined as described previously (16) . NT, not typeable. operating procedure (SOP) for PFGE typing of S. aureus, as previously described (11, 22) , was made available to participating centers. The S. aureus NCTC 8325 reference strain, used as a restriction fragment size marker in this SOP, was added to the panel for use as an internal standard. A fictitious hospital outbreak problem was submitted to each participant along with the panel. Several questions pertaining to outbreak control issues were asked, and a typing request was required in order to assess the ability of each center to make the appropriate epidemiological interpretation (Table 2) .
MATERIALS AND METHODS

Participants
Panel validation. Isolates were further genetically characterized by PCR analysis of the staphylococcal cassette chromosomal mec (SCCmec) element (23), multilocus sequence typing (MLST) (13), determination of accessory gene regulator (agr) type (16) , and spa typing using Ridom Staph Type software (18) . Isolates in both panels were classified into 10 sequence types (ST), 18 spa types, 4 SCCmec types, and 3 agr groups (Table 1) . Concordant classification into PFGE types, and classification obtained by the combination of MLST, SCCmec, spa, and agr analysis, was performed for 91% of MRSA isolates (data not shown). Discordances were observed for three S. aureus isolates: (i) one isolate classified as PFGE type K1 that presented an ST/SCCmec/spa/agr type (247/I/t075/1) similar to that of PFGE type A1 isolates, differing only by one deletion of two consecutive repeats in its spa allelic profile; (ii) one PFGE type F2 isolate that showed a combined type (8/IV/t121/1) similar to that of PFGE type A20, differing by one repeat deletion in its spa profile; and (iii) one PFGE type F3 isolate (susceptible to methicillin) that presented an ST/spa/agr profile (8/ t008/1) identical to that observed for MRSA PFGE A20 isolates (Table 1) .
Panel testing.
Participants were asked to analyze one panel per survey by the methods that were routinely used in their laboratory for epidemiological typing of S. aureus. Patterns were classified into types by each participant, who completed a table giving the type determined for each isolate. Participants also filled out a questionnaire about the testing procedure(s) (e.g., in-house, commercial, or the ULB PFGE SOP) and interpretation criteria used. Classification was verified by the coordinator based on gel pictures referred by participants. In addition, each participant completed the questionnaire about the hospital outbreak problem (Table 2) .
Data analysis. Data were returned electronically by individual laboratories to the coordinating center. The data included (i) type classification of all isolates, (ii) typing method and classification criteria used, and (iii) answers to the infection control questions. Performance was evaluated according to typeability, intralaboratory reproducibility in type assignment of identical isolates (duplicate strains), and discrimination of unrelated strains as recommended (26) . The discrimination index was determined by calculation of the Simpson index of diversity, D (19, 26) , for epidemiologically unrelated strains (SA5 to SA8 and SA11 to SA15 in the 2001 EQA; SA1, SA6 and SA15 to SA20 in the 2003 EQA). The concordance of type classification by local typing with the reference PFGE analysis was examined. Epidemiological concordance was evaluated by correct clonal grouping of isolates and ability to give the appropriate answers to the infection control questions (Table 2) .
RESULTS
Participation and typing methods used. A total of 11 centers participated in the EQA program, with 10 centers participating in each survey (Table 3) . Centers returned results within a median of 18 days (range, 2 to 66 days) of receipt of the proficiency panels. The majority of centers (7/10) performed PFGE analysis in both surveys, but they used different separation protocols and classification criteria. PFGE patterns were (Table 3) . Quality of patterns. Gel pictures or tagged-image format files obtained with DNA fingerprint methods were reviewed by the coordinator for scoring of quality and resolution. The ULB SOP and "in-house" separation protocols showed well-resolved PFGE analysis patterns (Fig. 1) . In contrast, center 2, which used the GenePath kit (Bio-Rad) for PFGE analysis, showed poorly resolved patterns due to an underload of DNA and faintly staining bands (Fig. 1) . Center 4 improved PFGE resolution and pattern quality in the second survey over that in the first survey after substituting the ULB SOP separation protocol (Fig. 1) . In the second survey, two centers obtained poorly resolved PFGE patterns due to suboptimal separation conditions (center 11) or showed faintly stained DNA bands (center 9). Centers using RAPD PCR analysis showed wellresolved amplified DNA patterns (Fig. 1) . One center that performed AFLP analysis showed well-resolved densitometric curves (data not shown). Sequence data from spa gene analysis performed in one center could not be scored for quality, because ABI sequence files were not sent to the coordinator.
Typeability and reproducibility. All centers obtained complete typeability for both strain panels with all methods (Table 5) . Excellent reproducibility with replicate strains (100%) was observed for all centers, except for one center that found a single DNA fragment difference in the PFGE profiles of a duplicate strain (Fig. 1B, center 4 , strain SA4). After repeat testing, the "additional" band was shown to be artifactual, resulting from incomplete DNA fragment digestion.
Discrimination. In both surveys, PFGE analysis showed a discrimination index of Ն96%, with the majority of centers displaying a D index of 100% (Table 5 ). Only three strain type misclassifications were noted for centers using PFGE typing, due to suboptimal separation conditions in one (center 11) and mislabeling of strain SA7 in two centers (centers 5 and 6). In contrast, RAPD PCR and inter-IS256 PCR typing showed lower discrimination index values, ranging between 72% and 80%, except for center 7, which achieved a D index of 97%. AFLP analysis also showed limited discrimination (D index, 86%). Sequencing of the spa gene, performed by center 10 as described by Shopsin et al. (25) , showed a D index of 93%.
Concordance of type classification with reference typing data. In both surveys, excellent concordance of type classification with the reference PFGE analysis, ranging from 85 to 100%, was obtained for centers using PFGE (Table 5) (11) Denis et al. (7) Visual ϩ computer SmaI PFGE ULB SOP (11) Denis et al. (7) Visual ϩ computer Because of the lower discrimination of RAPD and inter-IS256 PCR analysis, centers using these methods showed concordant type assignment with reference PFGE analysis for 47 and 87% of isolates, respectively. Discrepancies of these PCR typing results with PFGE analysis were also confirmed by MLST and spa analysis data. Center 1, using AFLP analysis, classified test isolates with 70% concordance with PFGE analysis and 85% concordance with MLST data. By using spa typing, center 10 obtained 80% concordance with PFGE analysis, 85% concordance with MLST data, and 89% concordance with spa typing data generated by using the Ridom Staph Type protocol and software. Interpretation of typing results. Epidemiological interpretation was evaluated according to answers given to the questions about the hospital infection control problem (Table 2 ). In the 2001 survey, all centers correctly recognized the existence of a clonal outbreak (Q1) and all but one center (center 8) identified the outbreak strain as the epidemic Belgian MRSA strain BE-B2 (Q2). This error was probably due to inversion between reference Belgian MRSA strains BE-A1 and BE-B2 by center 8 during testing. Due to the lower discrimination by IS256 and RAPD PCR typing, centers 1 and 8 incorrectly included unrelated strains as part of the outbreak and therefore provided inaccurate answers to questions related to the extent and potential source of the outbreak (Q3 and Q4) ( Tables 2 and 4 ). In contrast, in the 2003 survey, in spite of different discrimination levels and occasional discrepancies between typing methods, all centers interpreted their results appropriately and answered all infection control questions correctly.
Report and recommendations. An individual report summarizing the results of each survey was sent to each participating center. A global report on all results was made available on the CMD website (http://webhost.ua.ac.be/cmd/). Laboratories were each labeled with a confidential code. Reports scored the quality of the results and offered specific suggestions to improve methods or interpretation of results. These recommendations included (i) separation conditions for adequate resolution of PFGE patterns as validated in a previous multicenter study (22) , (ii) use of computer-assisted analysis verified by visual inspection to prevent misclassification of PFGE patterns, and (iii) caution against the use of rep-PCR and RAPD PCR as stand-alone methods for typing of S. aureus due to their limited discrimination.
DISCUSSION
We report on the first EQA surveys conducted with laboratories performing routine molecular typing of nosocomial pathogens with a variety of in-house methods, which were evaluated against reference typing based on PFGE typing. Typeability and within-run reproducibility were generally excellent. All centers that used PFGE analysis achieved excellent discrimination between outbreak-related and unrelated isolates based on validated criteria for PFGE profile interpretation (7, 27, 28) . Laboratories that used PFGE typing achieved better performance if they applied the ULB SOP or similar in-house protocols than if they used the GenePath reagent kit and protocol, as previously described in another multicenter study (31) . These findings underline the importance of using validated separation conditions for optimal resolution of DNA fragments. Use of computer-assisted pattern analysis verified by visual inspection helped to prevent misclassification (22) . This is crucial when a large number of S. aureus PFGE profiles are compared across multiple gels.
In contrast with the good performance obtained with PFGE typing, centers using single-primer PCR-based typing methods generally showed insufficient discrimination. This led some participants to perform incorrect classification of outbreakrelated and unrelated isolates. Among these PCR-based methods, the previously validated inter-IS256 PCR typing method (10) also presented low discrimination with the panel of isolates provided in the present study. This unexpectedly low discrimination may be due to genetic variation over time at the level of insertion element-like sequences in S. aureus isolates. Because of limited discrimination, isolates grouped together by indistinguishable RAPD/rep-PCR profiles should be confirmed as genotypically related either by further PCR testing with an additional primer(s) or, preferably, by another genotyping technique. Despite previous studies showing the good performance of AFLP analysis for typing L. pneumophila (14, 15) , Acinetobacter baumannii (6, 21) , and S. aureus (20) , the performance of AFLP as used by a single center also showed suboptimal discrimination for S. aureus typing in this survey.
DNA sequence-based typing approaches have become more frequently used because data are easily exchangeable between laboratories via the Internet. MLST is a discriminating method that scores the genetic variation accumulated relatively slowly in house keeping genes. MLST has been successfully used for global epidemiology and population genetic studies of S. aureus. It is less suitable for routine typing in outbreak investigations or local surveillance studies because of its high cost and workload. Single-locus DNA sequence analysis of hypervariable regions such as the repeat region of the spa gene (protein A) is a suitable method for S. aureus typing in a hospital setting (18, 25) . In the present study, one center that used spa typing achieved good performance. Commercial software (Ridom Staph Type) is available for spa typing analysis and interpretation according to an international spa nomenclature (1, 18) .
This study had an obvious limitation relating to its design: the "gold standard" criteria for typing results were defined on the basis of a particular method, PFGE typing with SmaI macrorestriction analysis. The better performance of PFGE typing over other methods was therefore to be expected based Table 2 ).
on the selection of isolate panels by PFGE classification into indistinguishable, clonally related, and unrelated patterns. Nevertheless, the strains used in the present study were characterized by extended genotypic analysis. These data confirmed that the clonal classification by PFGE patterns was robust. These variations illustrate the difficulty of defining the "gold standard" typing method, because each method explores different specific genomic regions (highly polymorphic or more conserved). The choice of typing method depends on the question asked (26) . Outbreak investigations require the use of methods with high discriminatory power, such as PFGE or spa typing. In the EQA surveys reported here, the goal was to assess the laboratories' abilities to delineate an outbreak of cross-infection and answer the infection control questions for implementation of appropriate control measures. Our findings underline the importance of using validated typing protocols irrespective of the typing strategy. All centers recognized the clonal outbreak, and the proportion capable of correctly answering the infection control questions increased in the second survey. We suggest that similar EQA surveys should be conducted to (i) evaluate the performance of typing laboratories, (ii) compare the effectiveness of routinely used methods, and (iii) provide recommendations to optimize method resolution and appropriate interpretation of results. These EQA exercises should be organized regularly and should include a range of nosocomial pathogens causing infection control problems.
